gvtcx

NHS National Pharmaceuticals Transition 2022_2

NHS England Published 4 Nov 2022 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£267,740,679
Statuscomplete
Category (CPV) 33600000
Deadline23 Aug 2022
Procedureopen
OCIDocds-h6vhtk-03538e

Awards (36)

This procurement was awarded to 18 suppliers. Values shown are per-award; the notice total is £267,740,679.

SupplierValueDateStatus
Accord-UK Ltd shared £35,745,737 1 Nov 2022 active
Accord-UK Ltd shared · · active
Amarox Limited shared £35,745,737 1 Nov 2022 active
Amarox Limited shared · · active
Ascend Laboratories UK Ltd shared £35,745,737 1 Nov 2022 active
Ascend Laboratories UK Ltd shared · · active
Aspire Pharma Limited shared £35,745,737 1 Nov 2022 active
Aspire Pharma Limited shared · · active
Cipla shared £35,745,737 1 Nov 2022 active
Cipla shared · · active
Colonis Pharma Ltd shared £35,745,737 1 Nov 2022 active
Colonis Pharma Ltd shared · · active
Dr.Reddy's Laboratories (UK) Limited shared £35,745,737 1 Nov 2022 active
Dr.Reddy's Laboratories (UK) Limited shared · · active
Gerot Lannach UK Ltd shared £35,745,737 1 Nov 2022 active
Gerot Lannach UK Ltd shared · · active
Glenmark Pharmaceuticals Europe Limited shared £35,745,737 1 Nov 2022 active
Glenmark Pharmaceuticals Europe Limited shared · · active
Milpharm Ltd/aurobinbdo shared £35,745,737 1 Nov 2022 active
Milpharm Ltd/aurobinbdo shared · · active
Morningside Pharmaeuticals shared £35,745,737 1 Nov 2022 active
Morningside Pharmaeuticals shared · · active
Mylan shared £35,745,737 1 Nov 2022 active
Mylan shared · · active
Pfizer Ltd shared £35,745,737 1 Nov 2022 active
Pfizer Ltd shared · · active
Selective Supplies Ltd. shared £35,745,737 1 Nov 2022 active
Selective Supplies Ltd. shared · · active
Takeda UK Ltd shared £35,745,737 1 Nov 2022 active
Takeda UK Ltd shared · · active
Teva UK Limited shared £35,745,737 1 Nov 2022 active
Teva UK Limited shared · · active
Thornton and Ross Ltd shared £35,745,737 1 Nov 2022 active
Thornton and Ross Ltd shared · · active
Wockhardt UK Limited shared £35,745,737 1 Nov 2022 active
Wockhardt UK Limited shared · · active

description

Invitation to offer for NHS National Pharmaceuticals Transition 2022_2<br/>Offer reference number: CM/PHG/22/5655<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>Transition: CESW: 01/12/2022 to 30/09/2023 (10 months)<br/>LSNE: 01/12/2022 to 31/05/2024 (18 months)<br/>NWLN: 01/12/2022 to 31/05/2023 (6 months)

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

6 notices published against this procurement.

PublishedTypeRegimeNotice
8 Jul 2022 Planning (planning) · af121852-1005-401f-9a5b-a30830caec6e-553130
19 Jul 2022 Contract notice (F02) Earlier regulations 019686-2022
19 Jul 2022 Tender (tender) · 26487991-3c18-4fae-9686-311c8f48460e-555872
26 Jul 2022 Corrigendum (F14) Earlier regulations 020378-2022
4 Nov 2022 Contract award notice (F03) Earlier regulations 031197-2022
4 Nov 2022 Award (award) · ce6948d4-7624-4e72-b9a5-a306a51c8142-586807

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.